Back to dashboard
MedicaidCoverageLow impact

BT202208: IHCP to reimburse pharmacy providers for select COVID-19 tests

Indiana Medicaid (IHCP)·IN·Pharmacy
Effective date
Feb 1, 2022
We identified it
Jun 19, 2026
Days to comply

Summary

Indiana Medicaid (IHCP) will now reimburse pharmacy providers for specific FDA-authorized COVID-19 home test kits, limited to 2 tests per member per week at $12.47500 per test. Seven specific test brands are covered including BinaxNOW, Ellume, Flowflex, InteliSwab, and QuickVue.

Action Required

Action needed
Immediately: Pharmacy staff must ensure proper NDC codes are used when billing for COVID-19 home test kits (see Table 1 for specific NDCs like 11877-0011-40 for BinaxNOW). Include prescriber NPI or use Indiana State Health Commissioner NPI 1730161647 for standing orders. Limit claims to 2 tests per member per 7-day period. File completed prescription orders for all test kit claims.